Everspin Technologies heads into its May 21 earnings report with insiders selling aggressively into the stock's extraordinary rally — and short sellers rapidly building positions in response.
The insider activity is the most striking feature of this setup. The CEO sold nearly 28,500 shares on May 4 at $19.58. The CFO followed with 11,000 shares on May 6. Then the Chairman offloaded 30,000 shares on May 11 at $37.16 — a $1.1 million transaction. A director added four separate sale tranches on May 15. In total, net insider selling over the past 90 days exceeded $3.9 million. These executives are distributing into a stock that has gained 156% in a single month — a signal worth watching closely heading into the print.
Short sellers have noticed. Short interest nearly doubled over the past month, climbing to 7.4% of the free float — up more than 106% from a month ago and 21% over the past week alone. The borrow market has tightened meaningfully: availability dropped from above 500% in late April to around 138% now, with an intraday low of 51.6% on May 14 marking the year's tightest reading. Cost to borrow remains low at under 1%, so the tightening reflects genuine demand for borrows rather than a supply squeeze. The ORTEX short score of 59.9, up sharply from 45 two weeks ago, confirms the shift in sentiment.
Options positioning adds another layer of nuance. The put/call ratio has risen to 0.24 — above its 20-day average of 0.17 — after running at ultra-low levels below 0.06 through most of April. That's a material shift: for a stock that spent a month with virtually no put demand, options traders are now buying meaningful downside protection. The z-score of 0.6 still places the ratio well inside normal bounds, so this is hedging rather than panic, but the directional change is clear.
The bull case rests on genuine fundamental catalysts: a $40 million U.S. defense RDT&E award, a strategic agreement with Microchip, and growing traction for the company's 1Gb STT-MRAM device in enterprise and defense markets. Needham raised its target to $18.50 on April 30, keeping a Buy rating — though that target now sits well below the current price of $31.72, highlighting how far the stock has run past even its most optimistic analyst. Bears point to slowing Toggle sales, rising OpEx, and an EV/EBITDA multiple that has compressed but still reads near 50x — expensive for a company where the quality score ranks near the bottom of the semiconductor universe.
The earnings print will test whether the operational momentum underlying the defense award and Microchip partnership has translated into numbers that justify a stock trading at a near-double-digit premium to its only covering analyst's revised target — and whether management's own aggressive selling into strength was well-timed.
See the live data behind this article on ORTEX.
Open MRAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
